Concepedia

Liam Cornell

LC

Statistics

Publications

5

Citations

540

H-Index

5

Active since

2007

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Dana-Farber Brigham Cancer Center

Newcastle University

Brigham and Women's Hospital

Liam Cornell is an author at Dana-Farber Cancer Institute specializing in molecular oncology, oncology, and medicine.

Publications per year

2007–2019

5

Publications

5

MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance

Liam Cornell, Seth A. Wander, Tanvi H. Visal et al. · Cell Reports · 2019 · 140 citations · Full text

, , +14

Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K

Joanne M. Munck, Michael A. Batey, Yan Zhao et al. · Molecular Cancer Therapeutics · 2012 · 131 citations · Full text

, , +11

Macrophage Depletion Suppresses Cardiac Allograft Vasculopathy in Mice

William H. Kitchens, Catharine M. Chase, Shuichiro Uehara et al. · American Journal of Transplantation · 2007 · 127 citations

, , +10

DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival

Liam Cornell, Joanne M. Munck, Clara Alsinet et al. · Clinical Cancer Research · 2014 · 88 citations · Full text

, , +17

Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in<i>KRAS</i>-mutant non-small cell lung cancer

Eric Haines, Ting Chen, Naveen Kommajosyula et al. · Oncotarget · 2018 · 54 citations · Full text

, , +17

1–5 of 5